Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0628-2022
Class II · Moderate risk

Sinus Severe

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-696-10 D-0627-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 49035-388-10 D-0626-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 36800-388-10 D-0625-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0624-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41163-703-10 D-0623-2022
Class II · Moderate risk

No Drip Nasal Decongestant

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 21130-801-10 D-0622-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11822-6319-1 D-0621-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0620-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-388-10 D-0619-2022
Class II · Moderate risk

Nasal Spray Decongestant

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0617-2022
Class II · Moderate risk

Maxiumum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-623-10 D-0616-2022
Class II · Moderate risk

No Drip Nasal Mist

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 59779-388-10 D-0615-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 72288-388-10 D-0614-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 72288-388-10 D-0613-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 36800-907-10 D-0612-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11673-935-10 D-0611-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41163-343-10 D-0610-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 21130-813-10 D-0609-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11822-6378-1 D-0608-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41520-108-10 D-0607-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41520-108-10 D-0605-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC D-0604-2022